BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25514036)

  • 1. Inhibition of osteoclastogenesis by osteoblast-like cells genetically engineered to produce interleukin-10.
    Fujioka K; Kishida T; Ejima A; Yamamoto K; Fujii W; Murakami K; Seno T; Yamamoto A; Kohno M; Oda R; Yamamoto T; Fujiwara H; Kawahito Y; Mazda O
    Biochem Biophys Res Commun; 2015 Jan; 456(3):785-91. PubMed ID: 25514036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts.
    Pathak JL; Bravenboer N; Verschueren P; Lems WF; Luyten FP; Klein-Nulend J; Bakker AD
    Osteoporos Int; 2014 Oct; 25(10):2453-63. PubMed ID: 25027107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.
    Kitaura H; Kimura K; Ishida M; Kohara H; Yoshimatsu M; Takano-Yamamoto T
    Clin Dev Immunol; 2013; 2013():181849. PubMed ID: 23762085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients.
    Lisignoli G; Piacentini A; Cristino S; Grassi F; Cavallo C; Cattini L; Tonnarelli B; Manferdini C; Facchini A
    J Cell Physiol; 2007 Mar; 210(3):798-806. PubMed ID: 17133360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.
    Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T
    J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
    Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
    J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclasts in arthritis and Th17 cell development.
    Okamoto K; Takayanagi H
    Int Immunopharmacol; 2011 May; 11(5):543-8. PubMed ID: 21081190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts.
    Bakker AD; Kulkarni RN; Klein-Nulend J; Lems WF
    J Dent Res; 2014 Apr; 93(4):394-9. PubMed ID: 24492932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.
    Kukita A; Kukita T; Nagata K; Teramachi J; Li YJ; Yoshida H; Miyamoto H; Gay S; Pessler F; Shobuike T
    Arthritis Rheum; 2011 Sep; 63(9):2744-54. PubMed ID: 21590684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.